| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.97B | +13.4% |
| Cost of Revenue | $7.72B | +10.4% |
| Gross Profit | $3.25B | +21.3% |
| R&D Expense | $144.0M | +17.1% |
| Operating Income | $1.13B | -37.8% |
| Interest Expense | $212.0M | +178.9% |
| Pre-tax Income | $916.0M | -42.4% |
| Income Tax | $275.0M | -31.4% |
| Net Income | $647.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $361.0M | -77.6% |
| Accounts Receivable | $1.24B | +26.0% |
| Inventory | $1.59B | +32.5% |
| Current Assets | $3.38B | -13.8% |
| Total Assets | $14.07B | +25.3% |
| Current Liabilities | $2.30B | -1.2% |
| Long-term Debt | $5.15B | +69.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.89B | +10.1% |
| Investing Cash Flow | -$3.39B | -853.1% |
| Financing Cash Flow | $334.0M | +138.1% |
| -45.9% |
| EPS (Basic) | $7.45 | -43.9% |
| EPS (Diluted) | $7.37 | -43.9% |
| Total Liabilities |
| $8.96B |
| +48.6% |
| Stockholders' Equity | $5.08B | -1.7% |